+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent advances with monoclonal antibody drug targeting for the treatment of human cancer



Recent advances with monoclonal antibody drug targeting for the treatment of human cancer



Bioconjugate Chemistry 1(1): 13-23




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 033103290

Download citation: RISBibTeXText

PMID: 2095201

DOI: 10.1021/bc00001a002


Related references

Recent advances in cancer research: drug targeting without the use of monoclonal antibodies. American Journal of Reproductive Immunology 21(3-4): 151-154, 1989

Recent advances in immunotherapy and monoclonal antibody treatment of cancer. Seminars in Oncology Nursing 16(4 Suppl 1): 2-12, 2001

Recent advances in drug-antibody immunoconjugates for the treatment of cancer. Drugs of the Future 28(9): 905-910, 2003

Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment. Current Medicinal Chemistry 24(23): 2505-2527, 2017

Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment. Cancer Science 108(3): 512-519, 2016

Recent advances in the generation of human monoclonal antibody. Cytotechnology 55(2-3): 55-60, 2008

Recent advances in cancer drug discovery targeting RAS. Drug Discovery Today 21(12): 1915-1919, 2016

Growth modulation of human cancer cell lines by free monoclonal antibody and a drug monoclonal antibody conjugate. Proceedings of the American Association for Cancer Research Annual Meeting 29: 419, 1988

Targeting the Human Epidermal Growth Factor Receptor 2 (Her2) in the Treatment of Breast Cancer: Recent Advances and Future Directions. Reviews on Recent Clinical Trials 2(2): 111-116, 2007

Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions. Reviews on Recent Clinical Trials 2(2): 111-116, 2008

Establishment of a human monoclonal antibody Gah, exhibiting a specific reactivity to viable cancer cells from fresh tissues and evaluation of the use of the antibody GAH in targeting cancer therapy. Proceedings of the American Association for Cancer Research Annual Meeting 42: 137, 2001

Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate. Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1391-1395, 1989

Targeting chemotherapy of colorectal cancer by monoclonal antibody conjugated antitumor drug. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt 2-1): 1060-1064, 1988

Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clinical Pharmacology and Therapeutics 83(5): 673-691, 2008

Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein. Current Medicinal Chemistry 24(40): 4488-4514, 2017